Berkshire Hathaway (BRK-B) to Acquire OxyChem for $9.7 Billion

Core Insights - Berkshire Hathaway Inc. has announced a definitive agreement to acquire Occidental's chemical business, OxyChem, for an all-cash transaction value of $9.7 billion, expected to conclude in Q4 2025 [1][2]. Group 1: Acquisition Details - The acquisition involves OxyChem, which manufactures essential commodity chemicals used in water treatment, pharmaceuticals, healthcare, and both commercial and residential development [2]. - OxyChem will become an operating subsidiary within Berkshire Hathaway, enhancing its portfolio of diverse businesses [3]. Group 2: Company Overview - Berkshire Hathaway Inc. is a multinational company engaged in various sectors, including insurance and reinsurance, utilities and energy, freight rail transportation, manufacturing, services, and retailing [3].